Cargando…
Bioequivalence Study of Oral Suspension and Intravenous Formulation of Edaravone in Healthy Adult Subjects
The neuroprotective agent edaravone is an intravenous treatment for amyotrophic lateral sclerosis. As intravenous administration burdens patients, orally administered treatments are needed. This phase 1, open‐label, single‐dose crossover study in 42 healthy adults evaluated bioequivalence of a 105‐m...
Autores principales: | Shimizu, Hidetoshi, Nishimura, Yukiko, Shiide, Youichi, Yoshida, Kaori, Hirai, Manabu, Matsuda, Munetomo, Nakamaru, Yoshinobu, Kato, Yuichiro, Kondo, Kazuoki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8518908/ https://www.ncbi.nlm.nih.gov/pubmed/33955162 http://dx.doi.org/10.1002/cpdd.952 |
Ejemplares similares
-
Evaluation of Pharmacokinetics, Safety, and Drug‐Drug Interactions of an Oral Suspension of Edaravone in Healthy Adults
por: Shimizu, Hidetoshi, et al.
Publicado: (2021) -
Edaravone Administered Orally and Via Nasogastric Tube in Healthy Adults: A Comparative Bioavailability Phase 1 Study
por: Shimizu, Hidetoshi, et al.
Publicado: (2022) -
A Randomized, Single‐Blind, Placebo‐Controlled, 3‐Way Crossover Study to Evaluate the Effect of Therapeutic and Supratherapeutic Doses of Edaravone on QT/QTc Interval in Healthy Subjects
por: Shimizu, Hidetoshi, et al.
Publicado: (2020) -
Bioequivalence of Different Formulations of Zonisamide Oral Suspensions: A Short Review
por: Stević, Ivana, et al.
Publicado: (2023) -
Bioequivalence of oral and intravenous carbamazepine formulations in adult patients with epilepsy
por: Tolbert, Dwain, et al.
Publicado: (2015)